Catalyst Pharmaceuticals CPRX

$ 21.16 -1.4%

Quarterly report 2024-Q3
added 11-06-2024

Catalyst Pharmaceuticals EV/EBITDA Ratio 2011-2024 | CPRX

Annual EV/EBITDA Ratio Catalyst Pharmaceuticals

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
7.16	5.86	10.6	-6.72	-12.9	-3.97	-6	-15.4	-8.58	-2.84	-2.92

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
10.6	-15.4	-3.25